234 related articles for article (PubMed ID: 26746857)
1. Phosphate and Klotho.
Kuro-O M
Kidney Int; 2011 Apr; 79121():S20-3. PubMed ID: 26746857
[TBL] [Abstract][Full Text] [Related]
2. Phosphate and Klotho.
Kuro-O M
Kidney Int Suppl; 2011 Apr; 79(121):S20-3. PubMed ID: 21346722
[TBL] [Abstract][Full Text] [Related]
3. Role of Klotho in aging, phosphate metabolism, and CKD.
John GB; Cheng CY; Kuro-o M
Am J Kidney Dis; 2011 Jul; 58(1):127-34. PubMed ID: 21496980
[TBL] [Abstract][Full Text] [Related]
4. Phosphate and FGF-23.
Jüppner H
Kidney Int; 2011 Apr; 79121():S24-7. PubMed ID: 26746858
[TBL] [Abstract][Full Text] [Related]
5. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
6. [Role of parathyroid hormone in Klotho-FGF23 system].
Kimura T; Shiizaki K; Kuro-O M
Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841
[TBL] [Abstract][Full Text] [Related]
7. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
Moe SM; Radcliffe JS; White KE; Gattone VH; Seifert MF; Chen X; Aldridge B; Chen NX
J Bone Miner Res; 2011 Nov; 26(11):2672-81. PubMed ID: 21826734
[TBL] [Abstract][Full Text] [Related]
8. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
Martin KJ; González EA
Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
10. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
11. New insights into the FGF23-Klotho axis.
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
13. [Pathologies of calcium-phosphate homeostasis].
Karczmarewicz E; Czekuć-Kryskiewicz E; Lorenc RS
Postepy Biochem; 2012; 58(4):474-7. PubMed ID: 23662440
[TBL] [Abstract][Full Text] [Related]
14. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
Sawires HK; Essam RM; Morgan MF; Mahmoud RA
Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
[TBL] [Abstract][Full Text] [Related]
15. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
[TBL] [Abstract][Full Text] [Related]
16. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
Kuro-o M
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
[TBL] [Abstract][Full Text] [Related]
17. Phosphate and FGF-23.
Jüppner H
Kidney Int Suppl; 2011 Apr; 79(121):S24-7. PubMed ID: 21346724
[TBL] [Abstract][Full Text] [Related]
18. The challenge of controlling phosphorus in chronic kidney disease.
Cannata-Andía JB; Martin KJ
Nephrol Dial Transplant; 2016 Apr; 31(4):541-7. PubMed ID: 25770169
[TBL] [Abstract][Full Text] [Related]
19. Aging and FGF23-klotho system.
Kuro-O M
Vitam Horm; 2021; 115():317-332. PubMed ID: 33706952
[TBL] [Abstract][Full Text] [Related]
20. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]